271 related articles for article (PubMed ID: 23481326)
1. Targeting miR-21 for the therapy of pancreatic cancer.
Sicard F; Gayral M; Lulka H; Buscail L; Cordelier P
Mol Ther; 2013 May; 21(5):986-94. PubMed ID: 23481326
[TBL] [Abstract][Full Text] [Related]
2. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3.
Li Z; Li X; Yu C; Wang M; Peng F; Xiao J; Tian R; Jiang J; Sun C
Tumour Biol; 2014 Dec; 35(12):11751-9. PubMed ID: 25344675
[TBL] [Abstract][Full Text] [Related]
4. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
[TBL] [Abstract][Full Text] [Related]
5. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
[TBL] [Abstract][Full Text] [Related]
6. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression.
Ding Y; Cao F; Sun H; Wang Y; Liu S; Wu Y; Cui Q; Mei W; Li F
Cancer Lett; 2019 Feb; 442():351-361. PubMed ID: 30419348
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.
Mody HR; Hung SW; AlSaggar M; Griffin J; Govindarajan R
Mol Cancer Res; 2016 Nov; 14(11):1124-1135. PubMed ID: 27624777
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
9. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
10. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.
Liu Q; Chen J; Wang J; Amos C; Killary AM; Sen S; Wei C; Frazier ML
Mol Carcinog; 2014 Sep; 53(9):711-21. PubMed ID: 23661430
[TBL] [Abstract][Full Text] [Related]
11. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
12. DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.
Sureban SM; May R; Qu D; Weygant N; Chandrakesan P; Ali N; Lightfoot SA; Pantazis P; Rao CV; Postier RG; Houchen CW
PLoS One; 2013; 8(9):e73940. PubMed ID: 24040120
[TBL] [Abstract][Full Text] [Related]
13. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
14. microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression.
Gu DN; Jiang MJ; Mei Z; Dai JJ; Dai CY; Fang C; Huang Q; Tian L
Cancer Lett; 2017 Aug; 400():69-78. PubMed ID: 28450156
[TBL] [Abstract][Full Text] [Related]
15. Mir-320b Inhibits Pancreatic Cancer Cell Proliferation by Targeting FOXM1.
Jingyang Z; Jinhui C; Lu X; Weizhong Y; Yunjiu L; Haihong W; Wuyuan Z
Curr Pharm Biotechnol; 2021; 22(8):1106-1113. PubMed ID: 32942974
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development.
Chu NJ; Anders RA; Fertig EJ; Cao M; Hopkins AC; Keenan BP; Popovic A; Armstrong TD; Jaffee EM; Zimmerman JW
Cancer Prev Res (Phila); 2020 Jul; 13(7):569-582. PubMed ID: 32409593
[TBL] [Abstract][Full Text] [Related]
17. The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool.
Delpu Y; Lulka H; Sicard F; Saint-Laurent N; Lopez F; Hanoun N; Buscail L; Cordelier P; Torrisani J
PLoS One; 2013; 8(1):e55513. PubMed ID: 23383211
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.
Kasloff SB; Pizzuto MS; Silic-Benussi M; Pavone S; Ciminale V; Capua I
J Virol; 2014 Aug; 88(16):9321-34. PubMed ID: 24899201
[TBL] [Abstract][Full Text] [Related]
19. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
